The recent NCCN Guidelines for Survivorship recommend systematic evaluation and multidisciplinary treatment of cancer-related sexual dysfunctions. However, most oncology professionals fail to routinely assess sexual problems and lack expertise to treat them. An Internetbased intervention was designed to educate female patients and their partners about cancer-related sexual problems, describe medical treatment options and how to find expert care, and provide self-help strategies. A randomized trial assessed efficacy of the intervention when used as self-help versus the same Web access and 3 supplemental counseling sessions. Survivors of localized breast or gynecologic cancers completed online questionnaires at baseline, posttreatment, and 3-and 6-month follow-up, including the Female Sexual Function Index (FSFI), the Menopausal Sexual Interest Questionnaire (MSIQ), the Brief Symptom Inventory-18 (BSI-18) to assess emotional distress, and the Quality of Life in Adult Cancer Survivors (QLACS) scale. Program evaluation ratings were completed posttreatment. Fifty-eight women completed baseline questionnaires (mean age, 53 ± 9 years). Drop-out rates were 22% during treatment and 34% at 6-month follow-up. Linear mixed models for each outcome across time showed improvement in total scores on the FSFI, MSIQ, and QLACS (P<.001) and BSI-18 (P=.001). The counseled group improved significantly more on sexuality measures, but changes in emotional distress and quality of life did not differ between groups. Program content and ease of use were rated positively. Research is needed on how best to integrate this intervention into routine clinical practice, and particularly how to improve uptake and adherence. (JNCCN 2013;11:1389-1397 Female sexual dysfunction is very common after cancer treatment. Two-thirds of the 7 million female cancer survivors in the United States were treated for breast, gynecologic, bladder, or colorectal malignancies, 1 and at least 50% experience long-term, severe sexual problems.
Female sexual dysfunction is very common after cancer treatment. Two-thirds of the 7 million female cancer survivors in the United States were treated for breast, gynecologic, bladder, or colorectal malignancies, 1 and at least 50% experience long-term, severe sexual problems. [2] [3] [4] The most common dysfunctions are vaginal dryness, pain, and decreased sexual desire. 2, 5, 6 The risk of sexual dysfunction is increased by abrupt ovarian failure, 5, 6 severe vaginal atrophy from using aromatase inhibitors, 7 direct genital damage from pelvic radiation therapy, [8] [9] [10] and genital graft-versus-host disease. 11 Urinary and fecal incontinence often lead to avoidance of sexual contact. 12 The recent NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Survivorship advocate systematic assessment of female sexual function and referral for multidisciplinary treatment (to view the most recent version of these guidelines, visit NCCN. org). 13 Unfortunately, women with cancer report few satisfying discussions about sexuality. 14, 15 Fewer than 20% of sexually dysfunctional women treated for cancer seek professional help, 3, 16, 17 and distress over sexual dysfunction ranks high in surveys of unmet needs of cancer survivors. 18, 19 Only a few gynecologists and mental health professionals have expertise in managing relevant physical symptoms of sexual dysfunction 20, 21 or in providing evidence-based cognitive behavioral treatment. [22] [23] [24] Furthermore, insurance coverage is poor, especially for mental health services.
An Internet-based intervention may be a cost-effective way for oncology settings to comply with the new guidelines. The authors recently showed that an Internetbased intervention for couples after prostate cancer treatment using e-mail contact with a therapist was as effective in improving sexual function as 3 in-person sessions of cognitive-behavioral therapy. 25 Pilot studies with Internet-based interventions for female sexual dysfunction have shown promise for healthy women 26 and in gynecologic cancer survivors. 27, 28 The authors created a Web site, Tendrils: Sexual Renewal for Women After Cancer, and tested a prototype in a randomized trial, comparing use on a self-help basis or supplemented with sexual counseling. The authors hypothesized that both groups would improve on self-report measures of sexual function and satisfaction, but that the counseled group would have a significantly larger gain.
Materials and Methods
The research protocol, including recruitment materials and Web site content, was approved by The University of Texas MD Anderson Institutional Review Board. All participants provided informed consent. No adverse events were reported. Eligible women were 1 to 7 years postdiagnosis of localized breast or gynecologic cancer, and off active treatment other than hormonal therapy. They scored as sexually dysfunctional (<26.5) on the Female Sexual Function Index (FSFI), 29 had been in a sexual relationship for at least 6 months, and had a partner willing to participate in behavioral homework. They lived close enough to attend 3 in-person counseling sessions, could read English, and had Internet access.
Recruitment
The study recruited for 16 months, and introductory letters and flyers were sent to 1123 women from the university's tumor registry who met eligibility criteria for cancer type, stage, and date of diagnosis. Flyers were given to the breast and gynecologic outpatient clinics, and some women were approached during outpatient clinic appointments. The study was also listed on ClinicalTrials.gov. Of 117 women screened for eligibility, 22 (19%) declined participation and 23 (20%) were ineligible.
Study Design
All women used the Web site for a 12-week treatment period. Half were adaptively randomized, using minimization, 30 to have 3 supplemental in-person counseling sessions. Minimization balanced treatment groups on the following factors: education (≥4-year college degree vs no college degree), age (≤49 years vs ≥50 years), current menopausal status, and cancer site (breast vs gynecologic).
Women completed questionnaires on the Web site at baseline, at the end of treatment, and at 3-and 6-month follow-up. Participants received a $20 gift card on completing questionnaires at each follow-up. Items assessed background and medical history. The FSFI was the primary outcome measure. 29 The FSFI is a 19-item, multiple-choice questionnaire with excellent internal consistency, discriminant validity, and test-retest reliability, and has been validated with female patients with cancer. 31 Subscales measure sexual desire, arousal, lubrication, orgasm, satisfaction, and pain. The total score reflects both function and satisfaction. One limitation is that scores are negatively biased if women have not been sexually active with a partner in the past 4 weeks. 31 The authors also included the Menopausal Sexual Interest Questionnaire (MSIQ), a 10-item scale with excellent internal consistency and test-retest reliability, with subscales measuring desire, responsiveness (pleasure and orgasm), and satisfaction. 32 The Brief Symptom Inventory-18 (BSI-18) assessed emotional distress with a Global Severity Index (GSI) summary score. 33 Norms are available for community samples and oncology patients. The Quality of Life in Adult Cancer Survivors (QLACS) scale yielded a summary score from its 47 items measuring global quality of life. 34, 35 At posttreatment, women rated the Tendrils program on 12 Likert scales.
Description of the Intervention
The password-protected Tendrils Web site included text, graphics, animations, and multicultural photographs and clipart. Instructions suggested an order for using the site, but women could navigate from the home page to sections describing the sexual and fertility consequences of their type of cancer and treatment; genital anatomy, including an interactive, vulvar self-portrait with pain and pleasure mapping; sex after menopause; managing vaginal dryness and pain (with detailed advice on vaginal moisturizers, lubricants, pelvic floor exercises, and dilators); causes and treatment options for loss of desire or orgasm problems; ways to improve body image; resuming sex comfortably using sensate focus exercises; sexual issues related to ostomies or incontinence; communication with sexual partners and health professionals; dating; lesbian relationships; and sex after childhood and adolescent cancer. Videos included 11 interviews with women cancer survivors and vignettes played by actors illustrating common problems and coping strategies.
A therapist manual provided overall guidance and content checklists for each of the 3 counseling sessions. Two master's-level mental health professionals provided counseling and were supervised weekly by the first author (LRS). Counselors guided women through the Web site and discussed behavioral homework.
Statistical Analyses
Demographic and clinical characteristics were summarized with means, standard deviations, ranges, and frequencies, and compared between intervention groups by Fisher test, t test, or a Wilcoxon rank sum test depending on the data distribution. Questionnaires were not scored if more than an allowed number of items were missing. Linear mixed models (LMM) were conducted to assess within and between group score changes over time for each outcome. 36 LMM is widely used in analyzing correlated longitudinal data because it accounts for missing data through incorporating random effects characterizing heterogeneity among subjects. Each outcome score was regressed onto time period, treatment group, and a time by treatment interaction. Post hoc analyses evaluated the changes across time points within and between groups. Similar LMM models analyzed the relationship of Web site use and outcomes. Figure 1 summarizes the number of women who entered the study and attrition. Seventy-two women provided informed consent and were minimized to a treatment group. However, 14% in the self-help group and 25% in the counseled group dropped out without completing baseline questionnaires (Fisher exact test; P=.372). For the 58 women who completed the baseline, attrition during the treatment period was similar in both groups (22%), but 34% did not complete 6-month follow-up questionnaires. To determine whether dropping out (defined as the last point at which a patient was missing data for all 4 questionnaires) was associated with specific participant characteristics, a discrete survival time model was conducted with terms for treatment group, each baseline questionnaire score, age, cancer site (breast vs gynecologic), education (≥4-year college degree vs no college degree), and time points. The area under the receiver operating characteristic curve was 0.885. The only significant factor was that younger women were more likely to drop out (odds ratio, 0.91; P=.034). Even though groups were balanced with regard to age, it was used as a covariate in outcome analyses. Table 1 presents demographic and medical factors characterizing the 58 women who completed baseline questionnaires. The self-help and counseled groups did not differ significantly on any variable. The sample was reasonably diverse (21% minority ethnicity) but well educated; 80% were treated for breast cancer.
Results

Attrition Over Time
Demographic and Medical Factors
Impact of Intervention on Questionnaire Scores
Our hypothesis was confirmed for sexual outcomes. When groups were combined, gains were significant from baseline to posttreatment on the FSFI (effect, 3.41; P<.001) and MSIQ (effect, 6.54; P<.001). Table 2 summarizes the results of LMMs analyzing within-group effects for total scores on each questionnaire. Figure 2 illustrates trends over time graphically for the 2 groups on each outcome measure. At posttreatment, total FSFI scores improved significantly (P<.001) for the counseled group, with a trend (P=.054) seen in the selfhelp group (between-group difference; P=.024). Comorbidities: the sum of the following factors: psychotropic medication, hypertension, cardiovascular disease, major depression, diabetes, thyroid disease, asthma, arthritis, chronic lung disease, and hepatitis C.
Although gains remained significant at 6-month follow-up, most women did not attain the 26.6 score considered to mark "normal sexual function." 29 The authors also examined FSFI results excluding women at each assessment who were not sexually active. 31 Although 40 fewer scores were included, the LMM analysis again revealed a significant treatment effect in the counseling group that was maintained over time. Figures 2A  and B show FSFI total scores across time for all women versus only sexually active women.
For the MSIQ, within-group treatment effects were highly significant for counseled women (P<.001) but fell short of significance for the selfhelp group (P=.082; between-group difference, P=.011). However, improvement for counseled women regressed at 6-month follow-up, whereas the self-help group improved slightly over time.
On nonsexual outcomes, distress (BSI-18 GSI scores) improved significantly across time (effect, -2.96; P=.001), as did the QLACS total score (effect, -13.73; P<.001). Table 2 shows that changes at posttreatment were only significant within the self-help group, however (GSI, P=.011; QLACS summary score, P=.008), with gains maintained at 6 months.
Use of the Web Site
Web site use was electronically recorded, excluding time spent completing questionnaires. For each participant, total minutes of use were calculated during the 12-week treatment period, between posttreatment and 6-month follow-up assessments, and across the entire study period. The treatment groups did not differ significantly on use during the treatment period Use across the entire study was very similar between groups, with the mean (SD) for the combined sample at 149.0 (157.1). However, between posttreatment and 6-month follow-up, the self-help group spent significantly more minutes on the Web site (self-help, 38.6 [60.9]; counseled, 7.6 [17.7] ; P=.015).
The authors performed linear regression analysis to determine whether more time on the site was associated with better outcomes on the FSFI and MSIQ. Models included terms for baseline or posttreatment score, use time, intervention group, and their interaction. Use time during a particular period was not associated with improvement on the FSFI or MSIQ. However, a trend was seen (P=.065) for use time across the entire study period to be associated with improvement in the 6-month MSIQ. Greater Web site use in the selfhelp group posttreatment was also consistent with the improvement seen in their scores during that time, in contrast to backsliding seen in the counseling group. Table 3 presents mean ratings by treatment group for 12 aspects of the intervention program. Ratings were in the positive range on all scales. The only significant difference between groups was that counseled women rated the intervention more positively on addressing emotional concerns. Women rated the counselors, in particular, as helpful and empathic. 
Posttreatment Program Ratings
Discussion
This randomized trial suggests that an Internetbased intervention can significantly improve sexual function and satisfaction in women with sexual dysfunction several years after treatment for breast or gynecologic cancer. Although supplemental in-person sexual counseling was associated with larger improvements during the treatment period, women in the self-help group were more likely to persist in using the Web site during the next 6 months. Their outcome measures improved slowly during that period, in contrast with some backsliding for counseled women, particularly on the MSIQ. The intervention also reduced emotional distress and improved ratings of overall quality of life at posttreatment, particularly within the selfhelp group. Younger women were more likely to drop out of the study. Although younger patients with cancer are more emotionally distressed, 37 baseline BSI-18 was not predictive of dropping out. Cancer disrupts more life roles for younger women, which may have interfered with taking time for the intervention. 37 Because of the sample size, the authors had limited power to identify demographic or medical factors that may influence the efficacy of the intervention. Questionnaire scores indicate that our participants had severe and pervasive sexual problems, even compared to similar cohorts. 29, 31, 38, 39 Although sexual function improved, most women did not achieve criteria for normalcy on the FSFI or MSIQ. However, the magnitude of improvement in the counseled group was similar to results associated with a 3-session, individual intervention using cognitive-behavioral sex therapy techniques with 31 survivors of gynecologic cancer. 38 As in that study, some backsliding occurred by 6 months, suggesting a need for relapse prevention.
Future research should focus on facilitating adoption of the intervention. Accrual for this study was disappointing. The intervention was difficult to publicize in a large cancer center. Sending letters to potential women was the most successful recruitment strategy, but more than half of women older than 50 years are sexually inactive. 40 With the proliferation of patient advocacy groups on the Internet social media may help publicize the intervention within a cancer center and in the community. 41 The choice of an inperson counseling format may also have discouraged some women who expressed reluctance to come to the cancer center for extra appointments, probably accounting for the greater drop-out rate in the counseled group after women found out their assigned treatment arm. Counseling may be more appealing if delivered by phone 42 or e-mail, 25 or through bulletin board 27, 28 or real-time 43 Internet groups. Attrition also needs to improve. Some women do not want to complete questionnaires because of the time involved or the sensitive nature of some items, accounting for drop-outs among women who gave informed consent but then failed to complete the baseline questionnaires, and women who finished the intervention but never completed a follow-up. 44 Nonadherence rates of 15% to 30% are common in randomized trials of interventions targeting psychological problems, with little evidence that attrition is worse in Internet-based formats. 44, 45 The next version of Tendrils will require fewer questionnaires and will use them interactively, prompting users to set short-term goals and track their progress with self-report instruments. 45 Web site usability also may have been a limitation. Despite overall positive evaluation ratings, the authors used a beta version of software that, when encrypted, no longer allowed searches using keywords or allowed direct links from one part of the text to another. Usability testing at the NCI laboratory revealed that the home page and navigation need reorganization. Text must be presented in shorter sections using more bullet lists.
Future research needs to identify the best formats for supplemental counseling. Adding human support enhances adherence to a range of eHealth interventions aimed at changing behavior, with self-guided interventions helping 15% or fewer of those who try them. 45 However, low-intensity Internet interventions attract people who do not seek professional help, sometimes stimulating them to get care. 46 In future effectiveness trials, the authors intend to test a sequential multiple assignment randomized trial (SMART) model, 47 starting with self-help use and adding medical referrals or more-intensive behavioral treatment on patient request, when women fail to use the Web site, or when outcome scores are poor. Although the Web site is designed for patients, oncology health professionals can learn from it and use the therapist manual to become comfortable providing assessment, brief counseling, and referrals for multidisciplinary care. More-extensive professional education can also be developed to implement the sexuality survivorship guideline.
